Literature DB >> 25261097

Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia.

Setareh Safavi1, Markus Hansson2, Karin Karlsson2, Andrea Biloglav3, Bertil Johansson4, Kajsa Paulsson1.   

Abstract

In contrast to acute lymphoblastic leukemia in children, adult cases of this disease are associated with a very poor prognosis. In order to ascertain whether the frequencies and patterns of submicroscopic changes, identifiable with single nucleotide polymorphism array analysis, differ between childhood and adult acute lymphoblastic leukemia, we performed single nucleotide polymorphism array analyses of 126 adult cases, the largest series to date, including 18 paired diagnostic and relapse samples. Apart from identifying characteristic microdeletions of the CDKN2A, EBF1, ETV6, IKZF1, PAX5 and RB1 genes, the present study uncovered novel, focal deletions of the BCAT1, BTLA, NR3C1, PIK3AP1 and SERP2 genes in 2-6% of the adult cases. IKZF1 deletions were associated with B-cell precursor acute lymphoblastic leukemia (P=0.036), BCR-ABL1-positive acute lymphoblastic leukemia (P<0.001), and higher white blood cell counts (P=0.005). In addition, recurrent deletions of RASSF3 and TOX were seen in relapse samples. Comparing paired diagnostic/relapse samples revealed identical changes at diagnosis and relapse in 27%, clonal evolution in 22%, and relapses evolving from ancestral clones in 50%, akin to what has previously been reported in pediatric acute lymphoblastic leukemia and indicating that the mechanisms of relapse may be similar in adult and childhood cases. These findings provide novel insights into the leukemogenesis of adult acute lymphoblastic leukemia, showing similarities to childhood disease in the pattern of deletions and the clonal relationship between diagnostic and relapse samples, but with the adult cases harboring additional aberrations that have not been described in pediatric acute lymphoblastic leukemia. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25261097      PMCID: PMC4281313          DOI: 10.3324/haematol.2014.112912

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  39 in total

1.  BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation.

Authors:  T Okada; A Maeda; A Iwamatsu; K Gotoh; T Kurosaki
Journal:  Immunity       Date:  2000-12       Impact factor: 31.745

2.  Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study.

Authors:  Luciana Annino; Maria Luce Vegna; Andrea Camera; Giorgina Specchia; Giuseppe Visani; Giuseppe Fioritoni; Felicetto Ferrara; Antonio Peta; Stefania Ciolli; Wilma Deplano; Francesco Fabbiano; Simona Sica; Francesco Di Raimondo; Nicola Cascavilla; Antonio Tabilio; Pietro Leoni; Rosangela Invernizzi; Michele Baccarani; Bruno Rotoli; Sergio Amadori; Franco Mandelli
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

3.  BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1.

Authors:  Martje Tönjes; Sebastian Barbus; Yoon Jung Park; Wei Wang; Magdalena Schlotter; Anders M Lindroth; Sabrina V Pleier; Alfa H C Bai; Daniela Karra; Rosario M Piro; Jörg Felsberg; Adele Addington; Dieter Lemke; Irene Weibrecht; Volker Hovestadt; Claudio G Rolli; Benito Campos; Sevin Turcan; Dominik Sturm; Hendrik Witt; Timothy A Chan; Christel Herold-Mende; Ralf Kemkemer; Rainer König; Kathrin Schmidt; William-Edmund Hull; Stefan M Pfister; Manfred Jugold; Susan M Hutson; Christoph Plass; Jürgen G Okun; Guido Reifenberger; Peter Lichter; Bernhard Radlwimmer
Journal:  Nat Med       Date:  2013-06-23       Impact factor: 53.440

Review 4.  Chromosomal translocations involving the IGH@ locus in B-cell precursor acute lymphoblastic leukemia: 29 new cases and a review of the literature.

Authors:  Elise Chapiro; Isabelle Radford-Weiss; Hong-Anh Cung; Nicole Dastugue; Nathalie Nadal; Sylvie Taviaux; Carole Barin; Stephanie Struski; Pascaline Talmant; Peter Vandenberghe; Marie-Joelle Mozziconacci; Isabelle Tigaud; Christine Lefebvre; Dominique Penther; Christian Bastard; Eric Lippert; Francine Mugneret; Serge Romana; Olivier A Bernard; Christine J Harrison; Lisa J Russell; Florence Nguyen-Khac
Journal:  Cancer Genet       Date:  2013-07-01

5.  TOX: an HMG box protein implicated in the regulation of thymocyte selection.

Authors:  Beverley Wilkinson; Jeff Y-F Chen; Peggy Han; Kevin M Rufner; Olivia D Goularte; Jonathan Kaye
Journal:  Nat Immunol       Date:  2002-02-19       Impact factor: 25.606

6.  Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials.

Authors:  Nicolas Boissel; Marie-Françoise Auclerc; Véronique Lhéritier; Yves Perel; Xavier Thomas; Thierry Leblanc; Philippe Rousselot; Jean-Michel Cayuela; Jean Gabert; Nathalie Fegueux; Christophe Piguet; Françoise Huguet-Rigal; Christian Berthou; Jean-Michel Boiron; Cécile Pautas; Gérard Michel; Denis Fière; Guy Leverger; Hervé Dombret; André Baruchel
Journal:  J Clin Oncol       Date:  2003-03-01       Impact factor: 44.544

7.  Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol.

Authors:  Nina Toft; Henrik Birgens; Jonas Abrahamsson; Per Bernell; Laimonas Griškevičius; Helene Hallböök; Mats Heyman; Mette Skov Holm; Erik Hulegårdh; Tobias Wirenfeldt Klausen; Hanne V Marquart; Olafur Gísli Jónsson; Ove Juul Nielsen; Petter Quist-Paulsen; Mervi Taskinen; Goda Vaitkeviciene; Kim Vettenranta; Ann Åsberg; Kjeld Schmiegelow
Journal:  Eur J Haematol       Date:  2013-04-02       Impact factor: 2.997

8.  BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.

Authors:  Norihiko Watanabe; Maya Gavrieli; John R Sedy; Jianfei Yang; Francesca Fallarino; Susan K Loftin; Michelle A Hurchla; Natalie Zimmerman; Julia Sim; Xingxing Zang; Theresa L Murphy; John H Russell; James P Allison; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2003-06-08       Impact factor: 25.606

9.  High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome.

Authors:  L Chilton; G Buck; C J Harrison; R P Ketterling; J M Rowe; M S Tallman; A H Goldstone; A K Fielding; A V Moorman
Journal:  Leukemia       Date:  2013-12-19       Impact factor: 11.528

10.  Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma.

Authors:  Wen Zhou; Xiangling Feng; Caiping Ren; Xingjun Jiang; Weidong Liu; Wei Huang; Zhihong Liu; Zan Li; Liang Zeng; Lei Wang; Bin Zhu; Jia Shi; Jie Liu; Chang Zhang; Yanyu Liu; Kaitai Yao
Journal:  Mol Cancer       Date:  2013-06-08       Impact factor: 27.401

View more
  20 in total

1.  Array-based comparative genomic hybridization detects copy number variations with prognostic relevance in 80% of ALL with normal karyotype or failed chromosome analysis.

Authors:  V Mühlbacher; T Haferlach; W Kern; M Zenger; S Schnittger; C Haferlach
Journal:  Leukemia       Date:  2015-10-09       Impact factor: 11.528

2.  Molecular profiling of gene copy number abnormalities in key regulatory genes in high-risk B-lineage acute lymphoblastic leukemia: frequency and their association with clinicopathological findings in Indian patients.

Authors:  Prerana Bhandari; Firoz Ahmad; Bibhu Ranjan Das
Journal:  Med Oncol       Date:  2017-04-11       Impact factor: 3.064

Review 3.  Pharmacogenetic Correlates of Antipsychotic-Induced Weight Gain in the Chinese Population.

Authors:  Chao Luo; Junyan Liu; Xu Wang; Xiaoyuan Mao; Honghao Zhou; Zhaoqian Liu
Journal:  Neurosci Bull       Date:  2019-01-03       Impact factor: 5.203

Review 4.  Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia.

Authors:  Rajesh Somasundaram; Mahadesh A J Prasad; Jonas Ungerbäck; Mikael Sigvardsson
Journal:  Blood       Date:  2015-05-19       Impact factor: 22.113

5.  BCR-ABL1 gene rearrangement as a subclonal change in ETV6-RUNX1-positive B-cell acute lymphoblastic leukemia.

Authors:  Karen A Dun; Rob Vanhaeften; Tracey J Batt; Louise A Riley; Giuseppe Diano; Jan Williamson
Journal:  Blood Adv       Date:  2016-11-30

Review 6.  TOX gene: a novel target for human cancer gene therapy.

Authors:  Xin Yu; Zheng Li
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

7.  Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysis.

Authors:  Wanhua Zhang; Pu Kuang; Ting Liu
Journal:  Ann Med       Date:  2019-02-14       Impact factor: 4.709

8.  Effect of IKZF1 deletions on signal transduction pathways in Philadelphia chromosome negative pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL).

Authors:  Naomi E van der Sligte; Frank J G Scherpen; Arja Ter Elst; Victor Guryev; Frank N van Leeuwen; Eveline S J M de Bont
Journal:  Exp Hematol Oncol       Date:  2015-08-12

9.  TOX expression in cutaneous B-cell lymphomas.

Authors:  Anne M R Schrader; Patty M Jansen; Rein Willemze
Journal:  Arch Dermatol Res       Date:  2016-05-14       Impact factor: 3.017

10.  Genetic and epigenetic characterization of hypodiploid acute lymphoblastic leukemia.

Authors:  Setareh Safavi; Linda Olsson; Andrea Biloglav; Srinivas Veerla; Molly Blendberg; Johnbosco Tayebwa; Mikael Behrendtz; Anders Castor; Markus Hansson; Bertil Johansson; Kajsa Paulsson
Journal:  Oncotarget       Date:  2015-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.